Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological Papers
Author
Abstract
Suggested Citation
DOI: 10.1177/0272989X19881654
Download full text from publisher
References listed on IDEAS
- Pasi Korhonen & Juni Palmgren, 2002. "Effect modification in a randomized trial under non‐ignorable non‐compliance: an application to the alpha‐tocopherol beta‐carotene study," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 51(1), pages 115-133, January.
- Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley, 2001. "The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 601-615, October.
- Cleemput, Irina & Kesteloot, Katrien & DeGeest, Sabina, 2002. "A review of the literature on the economics of noncompliance. Room for methodological improvement," Health Policy, Elsevier, vol. 59(1), pages 65-94, January.
- Jack Cuzick & Peter Sasieni & Jonathan Myles & Jonathan Tyrer, 2007. "Estimating the effect of treatment in a proportional hazards model in the presence of non‐compliance and contamination," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 69(4), pages 565-588, September.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Donald A. Redelmeier & Deva Thiruchelvam & Robert J. Tibshirani, 2022. "Testing for a Sweet Spot in Randomized Trials," Medical Decision Making, , vol. 42(2), pages 208-216, February.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Hiligsmann, Mickaël & Rabenda, Véronique & Bruyère, Olivier & Reginster, Jean-Yves, 2010. "The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients," Health Policy, Elsevier, vol. 96(2), pages 170-177, July.
- Karine Lamiraud & Pierre‐Yves Geoffard, 2007.
"Therapeutic non‐adherence: a rational behavior revealing patient preferences?,"
Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1185-1204, November.
- Karine Lamiraud & Pierre-Yves Geoffard, 2006. "Therapeutic non adherence: a rational behavior revealing patient preferences ?," PSE Working Papers halshs-00589121, HAL.
- Pierre-Yves Geoffard & Karine Lamiraud, 2007. "Therapeutic non adherence: A rational behavior revealing patient preferences?," PSE-Ecole d'économie de Paris (Postprint) halshs-00754193, HAL.
- Karine Lamiraud & Pierre-Yves Geoffard, 2006. "Therapeutic non adherence: a rational behavior revealing patient preferences ?," Working Papers halshs-00589121, HAL.
- Pierre-Yves Geoffard & Karine Lamiraud, 2007. "Therapeutic non adherence: A rational behavior revealing patient preferences?," Post-Print halshs-00754193, HAL.
- Karine Lamiraud & Pierre-Yves Geoffard, 2007.
"Therapeutic non-adherence: a rational behavior revealing patient preferences?,"
Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1185-1204.
- Karine Lamiraud & Pierre-Yves Geoffard, 2006. "Therapeutic non adherence: a rational behavior revealing patient preferences ?," PSE Working Papers halshs-00589121, HAL.
- Pierre-Yves Geoffard & Karine Lamiraud, 2007. "Therapeutic non adherence: A rational behavior revealing patient preferences?," Post-Print halshs-00754193, HAL.
- Katharina E. Blankart & Frank R. Lichtenberg, 2020. "Are patients more adherent to newer drugs?," Health Care Management Science, Springer, vol. 23(4), pages 605-618, December.
- Anna M. Wilke & Donald P. Green & Jasper Cooper, 2020. "A placebo design to detect spillovers from an education–entertainment experiment in Uganda," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 183(3), pages 1075-1096, June.
- Hege Urdahl & Andrea Manca & Mark Sculpher, 2006. "Assessing Generalisability in Model-Based Economic Evaluation Studies," PharmacoEconomics, Springer, vol. 24(12), pages 1181-1197, December.
- Stephens Alisa & Joffe Marshall & Keele Luke, 2016. "Generalized Structural Mean Models for Evaluating Depression as a Post-treatment Effect Modifier of a Jobs Training Intervention," Journal of Causal Inference, De Gruyter, vol. 4(2), pages 1-17, September.
- Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2015.
"Behavioral Hazard in Health Insurance,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(4), pages 1623-1667.
- Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2012. "Behavioral Hazard in Health Insurance," NBER Working Papers 18468, National Bureau of Economic Research, Inc.
- VanderWeele Tyler J, 2011. "Principal Stratification -- Uses and Limitations," The International Journal of Biostatistics, De Gruyter, vol. 7(1), pages 1-14, July.
- Rotar, Alexandru M. & Preda, Alin & Löblová, Olga & Benkovic, Vanesa & Zawodnik, Szymon & Gulacsi, Laszlo & Niewada, Maciej & Boncz, Imre & Petrova, Guenka & Dimitrova, Maria & Klazinga, Niek, 2018. "Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries," Health Policy, Elsevier, vol. 122(3), pages 230-236.
- Ana Teixeira & Maribel Teixeira & Maria Teresa Herdeiro & Viviana Vasconcelos & Rita Correia & Maria Fernanda Bahia & Isabel F. Almeida & Diogo Guedes Vidal & Hélder Fernando Pedrosa e Sousa & Maria A, 2021. "Knowledge and Practices of Community Pharmacists in Topical Dermatological Treatments," IJERPH, MDPI, vol. 18(6), pages 1-13, March.
- Hui Nie & Jing Cheng & Dylan S. Small, 2011. "Inference for the Effect of Treatment on Survival Probability in Randomized Trials with Noncompliance and Administrative Censoring," Biometrics, The International Biometric Society, vol. 67(4), pages 1397-1405, December.
- Afschin Gandjour & Karl Wilhelm Lauterbach, 2003. "When Is It Worth Introducing a Quality Improvement Program? A Mathematical Model," Medical Decision Making, , vol. 23(6), pages 518-525, November.
- Vincenzo Atella & Federico Belotti & Domenico Depalo, 2017.
"Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity,"
Health Economics, John Wiley & Sons, Ltd., vol. 26(S2), pages 106-126, September.
- Vincenzo Atella & Federico Belotti & Domenico Depalo, 2011. "Drug therapy adherence and health outcomes in presence of physician and patient unobserved heterogeneity," CEIS Research Paper 186, Tor Vergata University, CEIS, revised 22 Jun 2017.
- Stephens Alisa & Joffe Marshall & Keele Luke, 2016. "Generalized Structural Mean Models for Evaluating Depression as a Post-treatment Effect Modifier of a Jobs Training Intervention," Journal of Causal Inference, De Gruyter, vol. 4(2), pages 1, September.
- van Esch, Thamar E.M. & Brabers, Anne E.M. & van Dijk, Christel E. & Gusdorf, Lisette & Groenewegen, Peter P. & de Jong, Judith D., 2017. "Increased cost sharing and changes in noncompliance with specialty referrals in The Netherlands," Health Policy, Elsevier, vol. 121(2), pages 180-188.
- Linbo Wang & Eric Tchetgen Tchetgen & Torben Martinussen & Stijn Vansteelandt, 2023. "Instrumental variable estimation of the causal hazard ratio," Biometrics, The International Biometric Society, vol. 79(2), pages 539-550, June.
- Afschin Gandjour & Karl Wilhelm Lauterbach, 2005. "How Much Does It Cost to Change the Behavior of Health Professionals? A Mathematical Model and an Application to Academic Detailing," Medical Decision Making, , vol. 25(3), pages 341-347, May.
- Ditte Nørbo Sørensen & Torben Martinussen & Eric Tchetgen Tchetgen, 2019. "A causal proportional hazards estimator under homogeneous or heterogeneous selection in an IV setting," Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data, Springer, vol. 25(4), pages 639-659, October.
- Domenico Depalo, 2020.
"Explaining the causal effect of adherence to medication on cholesterol through the marginal patient,"
Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 110-126, October.
- Depalo, D.;, 2019. "Explaining the causal effect of adherence to medication on cholesterol through the marginal patient," Health, Econometrics and Data Group (HEDG) Working Papers 19/13, HEDG, c/o Department of Economics, University of York.
More about this item
Keywords
causal inference; cost-effectiveness analysis; medication nonadherence; noncompliance; survival analysis;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:39:y:2019:i:8:p:910-925. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.